Form 4: Elanco Director Stacey Ma Receives Equity Award

Elanco Animal Health Director Stacey Ma was granted 10,314 deferred stock units as an annual equity award.

Summary

• Stacey Ma, a Director of Elanco Animal Health Inc. (ELAN), received an equity award.
• The transaction involved the acquisition of 10,314 shares of Common Stock.
• These shares were granted as deferred stock units, part of an annual equity award for non-employee Board members.
• The grant price for these units was $0.
• Following this transaction, Stacey Ma beneficially owns 12,853 shares of Common Stock.
• The transaction date was November 28, 2025.

Sentiment

Score: 7

Explanation: The grant of equity to a director is generally positive as it aligns their interests with shareholders, promoting long-term value creation. It's a standard compensation practice.

Positives

• The grant of deferred stock units to Director Stacey Ma aligns her interests with those of shareholders, promoting long-term value creation.
• This is a standard practice for compensating non-employee directors, ensuring their commitment to the company's performance.

Negatives

• The issuance of new shares, even as deferred stock units, can lead to minor dilution for existing shareholders, though this specific grant is small in scale.

Future Outlook

NA

Industry Context

Equity compensation, particularly deferred stock units, is a common method for compensating non-employee directors across various industries to align their long-term interests with those of the company and its shareholders.

Comparison to Industry Standards

• The practice of granting equity awards to non-employee directors is a widely accepted corporate governance standard, comparable to practices at companies like Zoetis Inc. or IDEXX Laboratories, which also utilize equity-based compensation to attract and retain qualified board members.
• The specific structure of deferred stock units is common, allowing directors to defer receipt of shares, often until departure from the board, which can have tax benefits and further align long-term interests.

Corporate Governance

Stakeholder Impact

• Shareholders: Positive impact due to increased alignment of director interests with long-term company performance. Minor potential for dilution from the issuance of new shares.

Key Dates

Keywords

Elanco Animal Health, ELAN, Stacey Ma, Director, Form 4, Insider Transaction, Equity Award, Deferred Stock Units, Common Stock, Corporate Governance